Pozescaf Discovery Solutions

06/05/2026

We are excited to announce that PozeSCAF will be exhibiting at the BIO International Convention 2026 in San Diego from June 15–18, 2026.

Visit us at Booth #6152 to explore how PozeSCAF’s proprietary AxDrug™ platform is enabling integrated AI-driven drug discovery through the seamless combination of computational chemistry, medicinal chemistry, and in-vitro biology capabilities.

Dr. Ravi Kumar Muttineni will be representing PozeSCAF at BIO 2026 and looks forward to connecting with biotech and pharmaceutical partners seeking:
• AI-enabled discovery collaborations
• Hit identification and lead optimization support
• Integrated design–make–test workflows
• Discovery support for challenging and novel targets
• Flexible collaboration and co-development models

At PozeSCAF, we are focused on combining scientific depth, ex*****on speed, and capital-efficient discovery to help accelerate the path from target concept to high-quality lead candidates.

If you would like to schedule a meeting during BIO 2026, please feel free to book a meeting using the link below:
https://lnkd.in/g6tRpRYV

We look forward to meeting the global biotech community in San Diego.

20/04/2026

Thrilled to be at AACR Annual Meeting 2026 in San Diego, one of the world’s most influential gatherings in cancer research, where leading scientists, innovators, biotech companies, and global research organizations come together to shape the future of oncology.

PozeSCAF is proud to be exhibiting and engaging with the global scientific community over the next four days. This conference represents the very best of cutting-edge science, breakthrough ideas, and meaningful collaboration aimed at advancing cancer therapies worldwide.

We welcome researchers, biotech leaders, pharma teams, and partners to visit us and explore how PozeSCAF’s integrated AI-driven drug discovery platform can help accelerate your programs from concept to clinic through:

• AI & Computational Drug Design
• Medicinal Chemistry
• In Vitro Biology Services
• Integrated Discovery Partnerships
• Faster, smarter, scalable ex*****on

📍 Visit us at Booth #1542
🤝 Meet our Founder & Chief R&D Officer, Dr. Ravikumar Muttineni, PhD
📅 At AACR 2026 | San Diego

Come meet us and discover how we can help accelerate your next breakthrough in cancer drug discovery.

20/03/2026

On the auspicious occasion of Ugadi, we opened our new technology office at PozeSCAF.
This space marks an important step forward for us — designed to serve as the central hub for our AI, computational chemistry, and scientific discovery efforts. It brings together our growing team, advanced infrastructure, and a shared focus on accelerating high-quality drug discovery.
Ugadi represents new beginnings, and this milestone reflects our continued commitment to building thoughtfully, scaling responsibly, and delivering meaningful scientific outcomes.
Sharing a short video capturing moments from the inauguration and a glimpse of our new office.
Grateful to our team, partners, and well-wishers for their continued support.
hashtag hashtag hashtag hashtag hashtag hashtag hashtag

15/03/2026

Excited to share that PozeSCAF will be exhibiting at AACR Annual Meeting 2026 in San Diego.

Our AI-powered integrated drug discovery platform enables faster progression from target identification to experimental validation, combining computational design, medicinal chemistry, synthesis, and in-vitro biology.

📍 Booth #1542

15/03/2026

Looking forward to participating in Drug Discovery Chemistry 2026 in San Diego.

At PozeSCAF, we leverage an AI-powered integrated discovery platform to accelerate the progression from target identification to experimental validation.

📍 Booth #413

15/01/2026

PozeSCAF is at BIO Partnering @ JPM Week in San Francisco.

It has been a productive week of discussions with potential partners and investors focused on advancing differentiated science toward the clinic.

We look forward to continuing conversations around strategic collaboration and investment opportunities.

31/12/2025

From algorithms to atoms, and from insight to impact.
We build with intention, discover with intelligence, and advance science toward real-world outcomes.
Cheers to a year of promise.

25/12/2025

29/09/2025

🚀 PozeSCAF x AWS | Transforming Drug Discovery: Faster, Smarter, and Scalable**

We’re proud to be featured in an AWS Case Study –https://lnkd.in/gJanfBAt that highlights how **PozeSCAF** is leveraging the cloud to speed up and scale our drug discovery efforts.

💡 **By optimizing molecular dynamics workloads on AWS**, PozeSCAF reduced simulation runtime by more than **50%**—from 30 hours to under 15. Our teams now run about **2.5x more simulations** in the same timeframe, cutting new hit discovery time by an estimated **5%**.

In a typical preclinical phase of 3–5 years, this translates to **2–3 months of time saved**.

🧬 Our AWS-powered platform also enables:

* Large-scale screening of **millions of compounds** using AI-driven workflows
* Generation of novel compounds using generative AI techniques to explore new chemical space
* Prediction of critical **ADMET properties** to assess safety and efficacy early in the pipeline
* A **domain-specific knowledge graph** integrating biological, chemical, and clinical data for deeper, connected insights
* Scalable, cost-optimized infrastructure using services like **Amazon EC2, S3, RDS, Bedrock, ParallelCluster and SageMaker**, enabling seamless scaling of compute-heavy AI and machine learning and deep learning workloads

Thanks to our collaboration with AWS, we’ve created a robust foundation for scientific computing — one that reduces cost, accelerates time-to-discovery, and scales with the complexity of modern drug development.

** Faster hits. Smarter pipelines. PozeSCAF is rewriting the rules of drug discovery—stay tuned. **

📖 Full case study: https://lnkd.in/gJanfBAt

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

This link will take you to a page that’s not on LinkedIn